Stroke remains one of the leading causes of long-term disability worldwide. Even after the acute phase is managed, many survivors face months or years of rehabilitation with incomplete recovery of motor function, speech, and autonomic regulation. Vagus nerve stimulation (VNS) has emerged as one of the most promising adjunctive therapies for stroke rehabilitation — not as a replacement for physical therapy, but as a way to amplify the brain’s capacity to rewire itself during rehabilitation.
Why the Vagus Nerve Matters in Stroke
The vagus nerve intersects with stroke through two distinct mechanisms: neuroprotection during acute stroke (limiting damage) and neuroplasticity during recovery (promoting rewiring). Both stem from the vagus nerve’s unique position as the primary parasympathetic highway connecting the brain to the body’s inflammatory and neuromodulatory systems.
During an ischemic stroke, the inflammatory cascade that follows blood vessel blockage causes secondary damage to brain tissue surrounding the initial injury — the so-called penumbra. The vagus nerve activates the cholinergic anti-inflammatory pathway, a circuit where vagal efferent signals trigger the release of acetylcholine in the spleen, suppressing pro-inflammatory cytokine production (TNF-alpha, IL-1, IL-6). Animal studies have consistently shown that vagus nerve stimulation during or shortly after experimental stroke reduces infarct volume and improves neurological outcomes. However, translating this acute neuroprotection to human clinical practice remains challenging because the timing window is extremely narrow.
Vivistim: FDA-Cleared VNS for Stroke Rehabilitation
The more developed clinical application is VNS paired with rehabilitation therapy. The Vivistim system, developed by MicroTransponder (later acquired by Nuvectra), received FDA clearance in August 2021 for the treatment of moderate to severe upper extremity motor deficits in chronic ischemic stroke patients. This made it the first VNS device specifically cleared for stroke rehabilitation.
The VNS-REHAB pivotal trial randomised 108 chronic stroke patients (at least 9 months post-stroke with persistent upper limb impairment) to active VNS paired with intensive rehabilitation therapy versus sham VNS paired with the same therapy. The concept is pairing: a brief burst of vagus nerve stimulation is delivered at the precise moment the patient successfully performs a rehabilitation exercise, which triggers the release of neuromodulators (norepinephrine and acetylcholine) that enhance synaptic plasticity in the motor cortex. The brain learns faster when each correct movement is paired with a neuromodulatory signal.
Results showed that patients receiving active VNS achieved clinically meaningful improvement in upper extremity function at significantly higher rates than the sham group. The improvements persisted at one-year follow-up, suggesting that VNS-paired rehabilitation produces durable motor learning rather than temporary gains. Importantly, the rehabilitation protocol alone (sham group) also produced improvements — VNS amplified the effect of therapy that was already working.
Your local vagus nerve experts
Find a vagus nerve practitioner near you
Our directory lists 2,685 practitioners across the US, from polyvagal-informed therapists to HRV biofeedback clinics.
Or browse by approach
- Polyvagal-informed therapy
- Somatic therapy
- HRV biofeedback
- Craniosacral therapy
- Breathwork
- Insomnia therapy (CBT-I)
The directory covers the United States for now. Listings come from practitioners’ own websites and are not endorsements or medical advice. Browse the full directory.
How Paired VNS Works
The mechanism is timing-dependent neuroplasticity. When the vagus nerve is stimulated, it activates the locus coeruleus (the brain’s primary norepinephrine source) and the nucleus basalis (the primary acetylcholine source for the cortex). These neuromodulators are the brain’s own plasticity signals — they tell cortical circuits that whatever just happened is important and should be consolidated.
By delivering VNS at the exact moment of a successful rehabilitation movement, the therapy hijacks this natural learning mechanism. The motor cortex receives a stronger-than-normal plasticity signal precisely when the correct movement pattern is active, reinforcing those specific neural connections. Over hundreds of paired repetitions across weeks of therapy, the motor map in the cortex reorganises to support the recovered movement pattern.
This is different from traditional VNS used in epilepsy or depression, where stimulation is delivered on a fixed schedule regardless of behaviour. Paired VNS is specifically timed to coincide with the desired neural activity, which is why it requires a trained therapist to trigger stimulation during rehabilitation sessions.
Non-Invasive Approaches
Transcutaneous auricular VNS (taVNS) — stimulation of the vagus nerve branch in the ear using an external device — is being investigated as a non-invasive alternative for stroke rehabilitation. Several small clinical trials have paired taVNS with upper limb rehabilitation and reported improvements in motor function, though the evidence base is considerably smaller than for implanted VNS.
The potential advantages of taVNS are obvious: no surgery, lower cost, and greater accessibility. The potential disadvantage is that external stimulation may not activate central vagal pathways as reliably as direct nerve stimulation. Ongoing trials are working to establish whether taVNS produces comparable neuroplastic effects and to optimise stimulation parameters for stroke rehabilitation.
The Vagus Nerve and Post-Stroke Autonomic Dysfunction
Beyond motor recovery, the vagus nerve is relevant to post-stroke autonomic dysfunction — a common but under-recognised complication. Stroke, particularly when it affects the brainstem or insular cortex, can disrupt vagal regulation of heart rate, blood pressure, and gastrointestinal function. Post-stroke patients frequently exhibit reduced heart rate variability (a marker of impaired vagal tone), which is independently associated with increased mortality risk and poorer functional outcomes.
Addressing vagal tone through breathing exercises, structured physical activity, and potentially VNS may have benefits beyond motor rehabilitation, supporting cardiovascular stability and reducing the inflammatory burden that impedes recovery. This is an active area of investigation rather than established clinical practice.
Practical Takeaways
VNS for stroke is not speculative — it is an FDA-cleared therapy with pivotal trial evidence supporting its use in chronic stroke rehabilitation. However, it is currently available only through implanted devices at specialised rehabilitation centres, requires trained therapists to administer paired stimulation, and is indicated for a specific patient population (chronic ischemic stroke with moderate to severe upper limb impairment). It does not replace rehabilitation therapy — it enhances it.
For stroke survivors and their families, the key message is that neuroplasticity-based recovery continues well beyond the traditional 6-month window, and that emerging therapies like paired VNS are expanding what is achievable in chronic stroke rehabilitation. Discussing these options with a rehabilitation specialist is the appropriate next step.
Want to understand how the vagus nerve influences recovery, inflammation, and brain health? Get the Vagus Nerve & Me eBook for the complete science of vagal function.
